Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-017310
Filing Date
2025-06-13
Accepted
2025-06-13 19:30:06
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06132025_070601.html 4  
1 form4-06132025_070601.xml 4 6099
  Complete submission text file 0001415889-25-017310.txt   7574
Mailing Address C/O PMV PHARMACEUTICALS, INC. 8 CLARKE DRIVE, SUITE 3 CRANBURY NJ 08512
Business Address
Kung Winston (Reporting) CIK: 0001666963 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40475 | Film No.: 251048096

Mailing Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130
Business Address 10955 VISTA SORRENTO PARKWAY SUITE 200 SAN DIEGO CA 92130 (858) 751-4493
Janux Therapeutics, Inc. (Issuer) CIK: 0001817713 (see all company filings)

EIN.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)